American Association for Cancer Research
Browse
epi-23-0634_supplementary_table_s5_suppst5.docx (22.86 kB)

Supplementary Table S5 from Genetic Factors and Long-term Treatment-Related Neurocognitive Deficits, Anxiety, and Depression in Childhood Leukemia Survivors: An Exome-Wide Association Study

Download (22.86 kB)
journal contribution
posted on 2024-02-06, 08:20 authored by Kateryna Petrykey, Sarah Lippé, Serge Sultan, Philippe Robaey, Simon Drouin, Laurence Affret-Bertout, Patrick Beaulieu, Pascal St-Onge, Jessica L. Baedke, Yutaka Yasui, Melissa M. Hudson, Caroline Laverdière, Daniel Sinnett, Maja Krajinovic

Multivariable regression analysis for the Trail making test, male participants.

Funding

Institute of Cancer Research (IC)

Terry Fox Foundation (La Fondation Terry Fox)

C17 Children's Cancer and Blood Disorders (C17 Council)

Canadian Cancer Society Research Institute (CCSRI)

Ontario Institute for Cancer Research (OICR)

Pediatric Oncology Group of Ontario (POGO)

Garron Family Cancer Centre (GFCC)

History

ARTICLE ABSTRACT

An increased risk of neurocognitive deficits, anxiety, and depression has been reported in childhood cancer survivors. We analyzed associations of neurocognitive deficits, as well as anxiety and depression, with common and rare genetic variants derived from whole-exome sequencing data of acute lymphoblastic leukemia (ALL) survivors from the PETALE cohort. In addition, significant associations were assessed using stratified and multivariable analyses. Next, top-ranking common associations were analyzed in an independent SJLIFE replication cohort of ALL survivors. Significant associations were identified in the entire discovery cohort (N = 229) between the AK8 gene and changes in neurocognitive function, whereas PTPRZ1, MUC16, TNRC6C-AS1 were associated with anxiety. Following stratification according to sex, the ZNF382 gene was linked to a neurocognitive deficit in males, whereas APOL2 and C6orf165 were associated with anxiety and EXO5 with depression. Following stratification according to prognostic risk groups, the modulatory effect of rare variants on depression was additionally found in the CYP2W1 and PCMTD1 genes. In the replication SJLIFE cohort (N = 688), the male-specific association in the ZNF382 gene was not significant; however, a P value<0.05 was observed when the entire SJLIFE cohort was analyzed. ZNF382 was significant in males in the combined cohorts as shown by meta-analyses as well as the depression-associated gene EXO5. Further research is needed to confirm whether the current findings, along with other known risk factors, may be valuable in identifying patients at increased risk of these long-term complications. Our results suggest that specific genes may be related to increased neuropsychological consequences.

Usage metrics

    Cancer Epidemiology, Biomarkers & Prevention

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC